Materials • Major Chemicals
$13.19 ▼ -0.17
(-1.27%)
MKT CAP: $1.99B • VOL: 1.47M
52W L $10 52W H $29
ROARABLE / RQD
D • 48/100
PIOTROSKI
4 / 9
CC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.81B | $5.78B | $6.08B |
| YoY Revenue Growth % | +0.4% | -4.9% | — |
| Gross Profit | $902.0M | $1.14B | — |
| Gross Margin % | 15.5% | 19.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$386.0M | $69.0M | -$253.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $264.0M | -$633.0M | $556.0M |
| Capital Expenditures (CapEx) | $213.0M | $360.0M | — |
| Free Cash Flow (FCF) | $51.0M | -$993.0M | $556.0M |
| FCF Margin % | 0.9% | -17.2% | 9.1% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $670.0M | $713.0M | — |
| Total Debt (Short + Long Term) | $4.10B | $4.06B | — |
| Total Stockholders' Equity | $250.0M | $571.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CC.